EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan

Minoru Miyashita, Hiraku Kumamaru, Naoki Hayashi, Fuyo Kimura, Hiroyuki Yamamoto, Naoki Niikura, Yasuaki Sagara, Hiromitsu Jinno, Masakazu Toi, Shigehira Saji

Breast Cancer · 2025

DOI: 10.1007/s12282-025-01718-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Breast Cancer, 2025. Verfasst von Minoru Miyashita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgical Oncology, Tohoku University School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8574, Japan. minor…. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms, Early Detection of Cancer, Mass Screening. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is no comprehensive report regarding which patient groups were disrupted by the COVID-19 pandemic in Japan having universal health insurance system. To provide the guidance regarding how to act in future pandemics, we investigated the changes in breast cancer (BC) diagnosis and treatment during the COVID-19 pandemic.

Methods

The trends of monthly data were calculated in relation to the variables of a total of 291,018 primary BCs registered on the Japanese National Clinical Database between January 2018 and April 2021.

Results

An analysis of the nationwide data during the pandemic showed 9% decrease of newly identified BC compared with before the pandemic. The impact was more relevant in the 40–50, 51–60 and 61–70-years age groups (13%, 8% and 9% decrease, respectively). The most substantial reduction was noted in patients identified through screenings without symptoms with a 17% decrease. These effects were also apparent in cT1, cN0, cStage 0, and cStage I (11%, 9%, 8% and 11% decrease, respectively). In breast surgery procedures, there was a notable decrease in breast-conserving surgery (13%) as well as post-operative radiation therapy (11%). During this period, strategies using neoadjuvant endocrine therapy or chemotherapy were implemented to avoid treatment delays for especially Stage I patients (1.5 folds increase).

Conclusions

We have identified the patient groups that are more vulnerable to the effects of the pandemic. The changes during the pandemic might provide the guidance regarding how to act in future emergencies to minimize disadvantages for BC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Breast NeoplasmsEarly Detection of CancerMass ScreeningJapanPandemicsPandemic PreparednessMastectomy, SegmentalRadiotherapy, AdjuvantNeoadjuvant TherapyAntineoplastic Agents, HormonalChemotherapy, AdjuvantNeoplasm StagingHealth Services AccessibilityRetrospective StudiesHumansFemaleYoung AdultAdultMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

Breast cancerCOVID-19Japanese Breast Cancer SocietyNational clinical databasePandemicRegistry

Substanzen

Antineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgical Oncology, Tohoku University School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8574, Japan. minoru.miyashita.c6@tohoku.ac.jp.
  • Department of Healthcare Quality Assessment, University of Tokyo, 7-3-1 Hongo, , Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan.
  • Department of Breast, Tokyo Medical University Hospital, 6-7-1 Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
  • Department of Breast Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
  • Department of Breast Surgical Oncology, Social Medical Corporation Hakuaikai, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-833, Japan.

Zitieren

APA

Miyashita, M., Kumamaru, H., Hayashi, N., Kimura, F., Yamamoto, H., Niikura, N., Sagara, Y., Jinno, H., Toi, M., & Saji, S. (2025). Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan. Breast Cancer. https://doi.org/10.1007/s12282-025-01718-2

Vancouver

Miyashita M, Kumamaru H, Hayashi N, Kimura F, Yamamoto H, Niikura N, et al. Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan. Breast Cancer. 2025. doi:10.1007/s12282-025-01718-2

BibTeX
@article{Miyashita2025,
  author = {Miyashita, Minoru and Kumamaru, Hiraku and Hayashi, Naoki and Kimura, Fuyo and Yamamoto, Hiroyuki and Niikura, Naoki and Sagara, Yasuaki and Jinno, Hiromitsu and Toi, Masakazu and Saji, Shigehira},
  title = {Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan},
  journal = {Breast Cancer},
  year = {2025},
  doi = {10.1007/s12282-025-01718-2}
}
Kostenlos starten →